BGMS
NASDAQ · Biotechnology
Bio Green Med Solution Inc
$0.69
-0.02 (-3.39%)
Open$0.68
Previous Close$0.71
Day High$0.72
Day Low$0.66
52W High$2.80
52W Low$0.57
Volume—
Avg Volume13.0K
Market Cap5.71M
P/E Ratio—
EPS$-0.76
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+1,006.4% upside
Current
$0.69
$0.69
Target
$7.59
$7.59
$6.77
$7.59 avg
$11.85
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.27M | 1.16M | 1.19M |
| Net Income | -9,114,451 | -117,803 | -121,826 |
| Profit Margin | -401.3% | -10.2% | -10.2% |
| EBITDA | -10,564,658 | -246,829 | -223,977 |
| Free Cash Flow | — | -166,595 | -168,575 |
| Rev Growth | — | +16.9% | +20.6% |
| Debt/Equity | — | 0.36 | 0.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |